MedTrace Logo

Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands

NCT04488562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2023-02-15

No results posted yet for this study

Summary

To date, little is known about the short and long-term complications of COVID-19. In order to obtain more insights in disease course and recovery of COVID-19 and to improve care after hospital admission, patients with COVID-19 will be monitored at home using an online home monitoring program for a period of 1 year.

Conditions

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Dutch Society of Physicians for Pulmonology and Tuberculosis

    collaborator OTHER

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • M.S. Wijsenbeek, dr · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-19
Primary Completion
2021-08-26
Completion
2022-02-26

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04488562 on ClinicalTrials.gov